Anticancer Activity of Bacterial Proteins and Peptides

Despite much progress in the diagnosis and treatment of cancer, tumour diseases constitute one of the main reasons of deaths worldwide. The side effects of chemotherapy and drug resistance of some cancer types belong to the significant current therapeutic problems. Hence, searching for new anticancer substances and medicines are very important. Among them, bacterial proteins and peptides are a promising group of bioactive compounds and potential anticancer drugs. Some of them, including anticancer antibiotics (actinomycin D, bleomycin, doxorubicin, mitomycin C) and diphtheria toxin, are already used in the cancer treatment, while other substances are in clinical trials (e.g., p28, arginine deiminase ADI) or tested in in vitro research. This review shows the current literature data regarding the anticancer activity of proteins and peptides originated from bacteria: antibiotics, bacteriocins, enzymes, nonribosomal peptides (NRPs), toxins and others such as azurin, p28, Entap and Pep27anal2. The special attention was paid to the still poorly understood active substances obtained from the marine sediment bacteria. In total, 37 chemical compounds or groups of compounds with antitumor properties have been described in the present article.

[1]  K. Miyazaki,et al.  In vivo anti‐tumor activity of arginine deiminase purified from Mycoplasma arginini , 1992, International journal of cancer.

[2]  M. Botlagunta,et al.  In vitro anti-cancer activity of doxorubicin against human RNA helicase, DDX3 , 2016, Bioinformation.

[3]  G. Gellerman,et al.  Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells , 2016, Biomedicines.

[4]  N. Bernardes,et al.  Engineering of bacterial strains and their products for cancer therapy , 2013, Applied Microbiology and Biotechnology.

[5]  W. Hall,et al.  Targeting urokinase-type plasminogen activator receptor on human glioblastoma tumors with diphtheria toxin fusion protein DTAT. , 2002, Journal of the National Cancer Institute.

[6]  R. López-Gómez,et al.  Plant Antimicrobial Peptides as Potential Anticancer Agents , 2015, BioMed research international.

[7]  S. Bergelt,et al.  Listeriolysin O as cytotoxic component of an immunotoxin , 2009, Protein science : a publication of the Protein Society.

[8]  R. Fisher,et al.  Bleomycin in non-Hodgkin's lymphoma. , 1992, Seminars in oncology.

[9]  M. Tello,et al.  Antibacterial and antitumorigenic properties of microcin E492, a pore-forming bacteriocin. , 2009, Current pharmaceutical biotechnology.

[10]  Praveen P. Balgir,et al.  In Vitro Cytotoxicity of Native and Rec-Pediocin CP2 Against Cancer Cell Lines: A Comparative Study , 2012 .

[11]  Christine Egger,et al.  Administration of Bleomycin via the Oropharyngeal Aspiration Route Leads to Sustained Lung Fibrosis in Mice and Rats as Quantified by UTE-MRI and Histology , 2013, PloS one.

[12]  Marzieh Bagheri,et al.  Kefir: a powerful probiotics with anticancer properties , 2017, Medical Oncology.

[13]  R. Subramanian,et al.  Anticancer Properties of Highly Purified l-Asparaginase from Withania somnifera L. against Acute Lymphoblastic Leukemia , 2010, Applied biochemistry and biotechnology.

[14]  C. Wu,et al.  The molecular mechanism of actinomycin D in preventing neointimal formation in rat carotid arteries after balloon injury. , 2005, Journal of biomedical science.

[15]  J. Šmarda,et al.  Cytotoxic effects of colicins E1 and E3 on v-myb-transformed chicken monoblasts. , 2001, Folia biologica.

[16]  D. Kyriakidis,et al.  Antitumor activity of L-asparaginase from Thermus thermophilus , 2001, Anti-cancer drugs.

[17]  Y. Michel-Briand,et al.  The pyocins of Pseudomonas aeruginosa. , 2002, Biochimie.

[18]  T. Danciu,et al.  Nisin ZP, a Bacteriocin and Food Preservative, Inhibits Head and Neck Cancer Tumorigenesis and Prolongs Survival , 2015, PloS one.

[19]  Frank Y. S. Chuang,et al.  Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. , 2009, Cancer research.

[20]  T. Karpiński,et al.  Anti-cancer peptides from bacteria , 2013 .

[21]  Tina Hernandez-Boussard,et al.  Doxorubicin pathways: pharmacodynamics and adverse effects , 2011, Pharmacogenetics and genomics.

[22]  S. Heidorn,et al.  Genomics of Drug Sensitivity in Cancer , 2013, Definitions.

[23]  Y. Ni,et al.  Arginine deiminase, a potential anti-tumor drug. , 2008, Cancer letters.

[24]  C. Quinn,et al.  Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells. , 2001, Neurotoxicology.

[25]  N. I. Kalinovskaya,et al.  A New Antimicrobial and Anticancer Peptide Producing by the Marine Deep Sediment Strain “Paenibacillus profundus” sp. nov. Sl 79 , 2013, Natural product communications.

[26]  M. Marahiel,et al.  Learning from Nature's Drug Factories: Nonribosomal Synthesisof MacrocyclicPeptides , 2003, Journal of bacteriology.

[27]  T. Zendo,et al.  Purification, characterization and in vitro cytotoxicity of the bacteriocin from Pediococcus acidilactici K2a2-3 against human colon adenocarcinoma (HT29) and human cervical carcinoma (HeLa) cells , 2011 .

[28]  W. Coley.  The Treatment of Inoperable Sarcoma by Bacterial Toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus). , 1910, Proceedings of the Royal Society of Medicine.

[29]  Yongqi Huang,et al.  Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein–protein interactions and cancer therapy , 2017, Protein science : a publication of the Protein Society.

[30]  Ø. Fodstad,et al.  Synergistic Anticancer Effects of the 9.2.27PE Immunotoxin and ABT-737 in Melanoma , 2011, PloS one.

[31]  B. Hill,et al.  Evaluation of DNA repair inhibition by antitumor or antibiotic drugs using a chemiluminescence microplate assay. , 1997, Carcinogenesis.

[32]  I. Pastan,et al.  CAT-8015: A Second-Generation Pseudomonas Exotoxin A–Based Immunotherapy Targeting CD22-Expressing Hematologic Malignancies , 2009, Clinical Cancer Research.

[33]  C. Hetz,et al.  Microcin E492, a channel-forming bacteriocin from Klebsiella pneumoniae, induces apoptosis in some human cell lines , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  E. Kohn,et al.  L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer , 2012, Journal of cellular and molecular medicine.

[35]  S. Janakiraman,et al.  Growth inhibitory and proapoptotic effects of l‐asparaginase from Fusarium culmorum ASP‐87 on human leukemia cells (Jurkat) , 2017, Fundamental & clinical pharmacology.

[36]  L. Liu,et al.  Topoisomerase-targeting antitumor drugs. , 1989, Biochimica et biophysica acta.

[37]  Patrick D. Schloss,et al.  Status of the Archaeal and Bacterial Census: an Update , 2016, mBio.

[38]  P. Pompei,et al.  Inhibition of Adrenocortical Carcinoma by Diphtheria Toxin Mutant CRM197 , 2009, Chemotherapy.

[39]  C. Beattie,et al.  p28-Mediated Activation of p53 in G2-M Phase of the Cell Cycle Enhances the Efficacy of DNA Damaging and Antimitotic Chemotherapy. , 2016, Cancer research.

[40]  William H. Bisson,et al.  Causes of genome instability: the effect of low dose chemical exposures in modern society. , 2015, Carcinogenesis.

[41]  Takuji Tanaka,et al.  Cancer chemoprevention through the induction of apoptosis by natural compounds , 2012 .

[42]  V. Della Latta,et al.  Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions. , 2015, Pharmacological research.

[43]  S. Kaur,et al.  Bacteriocins as Potential Anticancer Agents , 2015, Front. Pharmacol..

[44]  P. Nagarajan,et al.  Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13 years after denileukin diftitox , 2017, JAAD case reports.

[45]  B. Shen,et al.  Bleomycin analogues preferentially cleave at the transcription start sites of actively transcribed genes in human cells. , 2017, The international journal of biochemistry & cell biology.

[46]  Henry J. Lin,et al.  Asparagine Depletion Potentiates the Cytotoxic Effect of Chemotherapy against Brain Tumors , 2014, Molecular Cancer Research.

[47]  Jiang-chun Hu,et al.  Isolation and characterization of a new iturinic lipopeptide, mojavensin A produced by a marine-derived bacterium Bacillus mojavensis B0621A , 2012, The Journal of Antibiotics.

[48]  J. Neglia,et al.  A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. , 2002, Blood.

[49]  G. Schuler,et al.  Immunogenic and tolerogenic effects of the chimeric IL-2-diphtheria toxin cytocidal agent Ontak® on CD25+ cells , 2014, Oncoimmunology.

[50]  P. Gaulard,et al.  Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. , 2011, Blood.

[51]  Qian Wang,et al.  Antifungal Cyclopeptides from Halobacillus litoralis YS3106 of Marine Origin. , 2002 .

[52]  M. C. Baracat-Pereira,et al.  Toxicity of bovicin HC5 against mammalian cell lines and the role of cholesterol in bacteriocin activity. , 2012, Microbiology.

[53]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[54]  A. Prakash,et al.  Bacteria in cancer therapy: a novel experimental strategy , 2010, Journal of Biomedical Science.

[55]  Kyung-Dall Lee,et al.  Tumor Cell Killing Enabled by Listeriolysin O-liposome-mediated Delivery of the Protein Toxin Gelonin* , 2003, Journal of Biological Chemistry.

[56]  J. Pezzuto,et al.  Arenamides A-C, cytotoxic NFkappaB inhibitors from the marine actinomycete Salinispora arenicola. , 2009, Journal of natural products.

[57]  O. Kuipers,et al.  Bacteriocins of lactic acid bacteria: extending the family , 2016, Applied Microbiology and Biotechnology.

[58]  D. Majumdar,et al.  A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt , 2011, Angiogenesis.

[59]  T. Karpiński,et al.  Characteristic of bacteriocines and their application. , 2013, Polish journal of microbiology.

[60]  A. Rickard,et al.  Biomedical applications of nisin , 2016, Journal of applied microbiology.

[61]  G. Kim,et al.  The Bacterial Protein Azurin Enhances Sensitivity of Oral Squamous Carcinoma Cells to Anticancer Drugs , 2011, Yonsei medical journal.

[62]  W. Goebel,et al.  Listeria Pathogenesis and Molecular Virulence Determinants , 2001, Clinical Microbiology Reviews.

[63]  A. Deezagi,et al.  Cytotoxic effects of pyocin S2 produced by Pseudomonas aeruginosa on the growth of three human cell lines. , 2004, Canadian journal of microbiology.

[64]  J. Kim,et al.  Ieodoglucomides A and B from a marine-derived bacterium Bacillus licheniformis. , 2012, Organic letters.

[65]  T. Ng,et al.  Marine Peptides: Bioactivities and Applications , 2015, Marine drugs.

[66]  M. Rabbani,et al.  Production and evaluation of cytotoxic effects of DT386-BR2 fusion protein as a novel anti-cancer agent. , 2016, Journal of microbiological methods.

[67]  B. Deslouches,et al.  Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications , 2017, Oncotarget.

[68]  P. Kinnunen,et al.  Interaction of the antimicrobial peptide pheromone Plantaricin A with model membranes: implications for a novel mechanism of action. , 2006, Biochimica et biophysica acta.

[69]  H. Byrne,et al.  An in vitro study of the interaction of the chemotherapeutic drug Actinomycin D with lung cancer cell lines using Raman micro‐spectroscopy , 2018, Journal of biophotonics.

[70]  Y. Kapila,et al.  Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1 , 2012, Cancer medicine.

[71]  M. Goto,et al.  Induction of apoptosis in macrophages by Pseudomonas aeruginosa azurin: tumour‐suppressor protein p53 and reactive oxygen species, but not redox activity, as critical elements in cytotoxicity , 2003, Molecular microbiology.

[72]  B. Kreikemeyer,et al.  Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo , 2015, Cancer biology & therapy.

[73]  C. Myers,et al.  Padanamides A and B, highly modified linear tetrapeptides produced in culture by a Streptomyces sp. isolated from a marine sediment. , 2011, Organic letters.

[74]  Sy Teisan,et al.  Lajollamycin, a Nitro-tetraene Spiro-β-lactone-γ-lactam Antibiotic from the Marine Actinomycete Streptomyces nodosus , 2005 .

[75]  X. Yao,et al.  Three new cytotoxic cyclic acylpeptides from marine Bacillus sp. , 2004, Chemical & pharmaceutical bulletin.

[76]  R. Holmes,et al.  Biology and molecular epidemiology of diphtheria toxin and the tox gene. , 2000, The Journal of infectious diseases.

[77]  Praveen P. Balgir,et al.  Sequence analysis and homology based modeling to assess structure-function relationship of Pediocin CP2 of Pediococcus acidilactici MTCC 5101 , 2010 .

[78]  Y. Rustum,et al.  Pharmacologic rationale for fluoropyrimidine-leucovorin combination: biochemical mechanisms. , 1992, Seminars in oncology.

[79]  D. Dykhuizen.  Species Numbers in Bacteria. , 2005, Proceedings. California Academy of Sciences.

[80]  A. Bull,et al.  Proximicin A, B and C, Novel Aminofuran Antibiotic and Anticancer Compounds Isolated from Marine Strains of the Actinomycete Verrucosispora† , 2008, The Journal of Antibiotics.

[81]  H. Saito,et al.  Cytotoxicity of pyocin S2 to tumor and normal cells and its interaction with cell surfaces. , 1980, Biochimica et biophysica acta.

[82]  F. Izzo,et al.  Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  S. Bundale,et al.  Immunomodulatory efficacy of nisin—a bacterial lantibiotic peptide , 2011, Journal of peptide science : an official publication of the European Peptide Society.

[84]  S. Hampel,et al.  Doxorubicin synergism and resistance reversal in human neuroblastoma BE(2)C cell lines: An in vitro study with dextran‐catechin nanohybrids , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[85]  K. Hahm,et al.  Functional and structural characteristics of anticancer peptide Pep27 analogues , 2005, Cancer Cell International.

[86]  S. Raguz,et al.  Resistance to chemotherapy: new treatments and novel insights into an old problem , 2008, British Journal of Cancer.

[87]  D. Vallera,et al.  A Deimmunized Bispecific Ligand-Directed Toxin That Shows an Impressive Anti–Pancreatic Cancer Effect in a Systemic Nude Mouse Orthotopic Model , 2012, Pancreas.

[88]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[89]  Torsten Schwede,et al.  The SWISS-MODEL Repository and associated resources , 2008, Nucleic Acids Res..

[90]  F. Bendali,et al.  Bacteriocins: Not Only Antibacterial Agents , 2016, Probiotics and Antimicrobial Proteins.

[91]  D. Majumdar,et al.  A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells , 2009, Molecular Cancer Therapeutics.

[92]  P. Jensen,et al.  Piperazimycins: cytotoxic hexadepsipeptides from a marine-derived bacterium of the genus Streptomyces. , 2007, The Journal of organic chemistry.

[93]  D. Kaufman,et al.  Targeting Tumor-Initiating Cancer Cells with dCD133KDEL Shows Impressive Tumor Reductions in a Xenotransplant Model of Human Head and Neck Cancer , 2011, Molecular Cancer Therapeutics.

[94]  E. Lara-Padilla,et al.  Effect of botulinum toxin A on proliferation and apoptosis in the T47D breast cancer cell line. , 2013, Asian Pacific Journal of Cancer Prevention.

[95]  Y. Matsuo,et al.  Urukthapelstatin A, a Novel Cytotoxic Substance from Marine-derived Mechercharimyces asporophorigenens YM11-542 , 2007, The Journal of Antibiotics.

[96]  D. Majumdar,et al.  Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[97]  B. Pati,et al.  New insights into the bioactivity of peptides from probiotics. , 2016, Frontiers in bioscience.

[98]  C. Shaw,et al.  Dermaseptin-PH: A Novel Peptide with Antimicrobial and Anticancer Activities from the Skin Secretion of the South American Orange-Legged Leaf Frog, Pithecopus (Phyllomedusa) hypochondrialis , 2017, Molecules.

[99]  K. Shin‐ya,et al.  Urukthapelstatin A, a Novel Cytotoxic Substance from Marine-derived Mechercharimyces asporophorigenens YM11-542 , 2007, The Journal of Antibiotics.

[100]  S. Hecht,et al.  Characterization of bleomycin-mediated cleavage of a hairpin DNA library. , 2013, Biochemistry.

[101]  C. Pui,et al.  L‐asparaginase treatment in acute lymphoblastic leukemia , 2011, Cancer.

[102]  P. Williams,et al.  Lucentamycins A-D, cytotoxic peptides from the marine-derived actinomycete Nocardiopsis lucentensis. , 2007, Journal of natural products.

[103]  K. Hahm,et al.  Mode of antibacterial action of a signal peptide, Pep27 from Streptococcus pneumoniae. , 2007, Biochemical and biophysical research communications.

[104]  J. Šmarda,et al.  Human tumor cells are selectively inhibited by colicins , 2008, Folia Microbiologica.

[105]  Y. Matsuo,et al.  Mechercharmycins A and B, Cytotoxic Substances from Marine-derived Thermoactinomyces sp. YM3-251 , 2005, The Journal of Antibiotics.

[106]  R. Kaur,et al.  Purification of a dimeric arginine deiminase from Enterococcus faecium GR7 and study of its anti-cancerous activity. , 2016, Protein expression and purification.

[107]  M. Koba,et al.  [Actinomycin D and its mechanisms of action]. , 2005, Postepy higieny i medycyny doswiadczalnej.

[108]  D. Majumdar,et al.  Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer , 2004, Oncogene.

[109]  J. Barbieri,et al.  Toxins from bacteria. , 2010, EXS.

[110]  M. Bally,et al.  The liposomal formulation of doxorubicin. , 2005, Methods in enzymology.

[111]  H. Kasai,et al.  Ariakemicins A and B, novel polyketide-peptide antibiotics from a marine gliding bacterium of the genus Rapidithrix. , 2008, Organic letters.

[112]  D. Hoover,et al.  Human β-defensins , 2006, Cellular and Molecular Life Sciences CMLS.

[113]  J. Encinar,et al.  An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs , 2017, Molecules.

[114]  R. Duarte,et al.  Lantibiotics produced by Actinobacteria and their potential applications (a review). , 2017, Microbiology.

[115]  G. Hoser,et al.  Cytotoxicity of Bacterial Metabolic Products, including Listeriolysin O, on Leukocyte Targets , 2012, Journal of biomedicine & biotechnology.

[116]  C. Barrow,et al.  Nonribosomal Peptides from Marine Microbes and Their Antimicrobial and Anticancer Potential , 2017, Front. Pharmacol..

[117]  D. Oh,et al.  Ohmyungsamycins A and B: cytotoxic and antimicrobial cyclic peptides produced by Streptomyces sp. from a volcanic island. , 2013, The Journal of organic chemistry.

[118]  J. Bomalaski,et al.  Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[119]  W. T. Bradner,et al.  Mitomycin C: a clinical update. , 2001, Cancer treatment reviews.

[120]  J. Verweij,et al.  Mitomycin C. , 1990, Cancer chemotherapy and biological response modifiers.

[121]  Se-Kwon Kim,et al.  Bioactive Peptide of Marine Origin for the Prevention and Treatment of Non-Communicable Diseases , 2017, Marine drugs.

[122]  D. Chiappetta,et al.  Doxorubicin: nanotechnological overviews from bench to bedside. , 2017, Drug discovery today.

[123]  G. Karsenty,et al.  Botulinum Toxin Type A Inhibits the Growth of LNCaP Human Prostate Cancer Cells In Vitro and In Vivo , 2009, The Prostate.

[124]  R. Tewari,et al.  Effect of nisin and doxorubicin on DMBA-induced skin carcinogenesis—a possible adjunct therapy , 2015, Tumor Biology.

[125]  D. Rawat,et al.  Marine Peptides as Anticancer Agents: A Remedy to Mankind by Nature. , 2017, Current protein & peptide science.

[126]  A. Gautam,et al.  Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10 , 2017, Scientific Reports.